| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Taiwan Liposome Company Ltd (TWO: 4152)
4152 Technical Analysis
5
| As on 7th Oct 2021 4152 STOCK Price closed @ 99.60 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 78.83 & Strong Buy for SHORT-TERM with Stoploss of 61.51 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4152STOCK Price
| Open | 99.60 | Change | Price | % |
| High | 99.60 | 1 Day | 0.00 | 0.00 |
| Low | 99.60 | 1 Week | 0.30 | 0.30 |
| Close | 99.60 | 1 Month | -0.90 | -0.90 |
| Volume | N/A | 1 Year | 37.10 | 59.36 |
| 52 Week High 107.00 | 52 Week Low 50.30 | ||||
TWO Taiwan Most Active Stocks
| 8111 | 53.00 | 1.53% |
| 4510 | 48.25 | -0.31% |
| 4931 | 63.70 | -2.45% |
| 4991 | 122.50 | 5.15% |
| 1815 | 28.10 | -3.93% |
| 3211 | 190.50 | 2.70% |
| 8071 | 22.00 | 1.15% |
| 4979 | 171.50 | -2.00% |
| 3264 | 54.30 | -1.45% |
| 6188 | 104.00 | -4.59% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 4152 Daily Charts |
4152 Intraday Charts |
Whats New @ Bazaartrend |
4152 Free Analysis |
|
|
4152 Important Levels Intraday
| RESISTANCE | 99.60 |
| RESISTANCE | 99.60 |
| RESISTANCE | 99.60 |
| RESISTANCE | 99.60 |
| RESISTANCE | 99.60 |
| RESISTANCE | 99.60 |
| RESISTANCE | 99.60 |
| RESISTANCE | 99.60 |
4152 Forecast December 2024
| 4th UP Forecast | 114.82 |
| 3rd UP Forecast | 109.94 |
| 2nd UP Forecast | 106.92 |
| 1st UP Forecast | 103.91 |
| 1st DOWN Forecast | 95.29 |
| 2nd DOWN Forecast | 92.28 |
| 3rd DOWN Forecast | 89.26 |
| 4th DOWN Forecast | 84.38 |
4152 Weekly Forecast
| 4th UP Forecast | 109.43 |
| 3rd UP Forecast | 106.28 |
| 2nd UP Forecast | 104.33 |
| 1st UP Forecast | 102.38 |
| 1st DOWN Forecast | 96.82 |
| 2nd DOWN Forecast | 94.87 |
| 3rd DOWN Forecast | 92.92 |
| 4th DOWN Forecast | 89.77 |
4152 Forecast2024
| 4th UP Forecast | 218.5 |
| 3rd UP Forecast | 180.37 |
| 2nd UP Forecast | 156.8 |
| 1st UP Forecast | 133.23 |
| 1st DOWN Forecast | 65.97 |
| 2nd DOWN Forecast | 42.4 |
| 3rd DOWN Forecast | 18.83 |
| 4th DOWN Forecast | -19.3 |
Taiwan Liposome Company Ltd ( TWO Taiwan Symbol : 4152 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4152 Business Profile
Taiwan Liposome Company, Ltd., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of nanomedicines that combine its proprietary lipid-assembled drug delivery platform with approved active pharmaceutical ingredients (APIs). The BioSeizer lipid formulation technology is designed to enable local sustained release and fast onset of APIs at the site of disease or injury with enhanced pharmacokinetic (PK) control by customization of lipid layers; and NanoX active drug loading technology enables the potential for reduced dosing frequency and enhanced distribution of liposome-encapsulated APIs to the desired site. Its lead product candidate is TLC599, an intraarticular injectable BioSeizer formulation of the API steroid dexamethasone sodium phosphate (DSP), which is in Phase III clinical trial for the treatment of knee osteoarthritis pain. The company's product candidates also comprise TLC590, a non-opioid BioSeizer formulation of the API ropivacaine that has completed Phase II clinical trial to treat post-surgical pain; TLC399, a multilamellar and multivesicular BioSeizer formulation of DSP, which is in Phase II clinical trial for ophthalmology indications; TLC178, an API that is in Phase I/II dose escalation trial to treat rhabdomyosarcoma; and TLC19 that is in Phase I clinical trial to treat COVID-19.Taiwan Liposome Company, Ltd. was founded in 1997 and is headquartered in Taipei, Taiwan. Address: No. 3 Yuanqu Street, Taipei, Taiwan, 11503
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service